NASDAQ:MTBC - Medical Transcription Billing Stock Price, Forecast & News

Medical Transcription Billing trades on the NASDAQ under the ticker symbol "MTBC."

Medical Transcription Billing Corp (NASDAQ:MTBC) issued its quarterly earnings data on Wednesday, November, 6th. The technology company reported ($0.14) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.14). The technology company earned $16.85 million during the quarter, compared to the consensus estimate of $16.06 million. Medical Transcription Billing had a negative net margin of 5.01% and a negative return on equity of 8.85%. View Medical Transcription Billing's Earnings History.

Medical Transcription Billing is scheduled to release their next quarterly earnings announcement on Friday, February 28th 2020. View Earnings Estimates for Medical Transcription Billing.

Medical Transcription Billing will be holding an earnings conference call on Friday, February 28th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Medical Transcription Billing issued an update on its FY 2020 IntraDay earnings guidance on Friday, February, 14th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $100 million, compared to the consensus revenue estimate of $100.4 million.

4 brokerages have issued 12-month price targets for Medical Transcription Billing's stock. Their forecasts range from $6.00 to $6.25. On average, they anticipate Medical Transcription Billing's stock price to reach $6.08 in the next twelve months. This suggests that the stock has a possible downside of 7.9%. View Analyst Price Targets for Medical Transcription Billing.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medical Transcription Billing in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Medical Transcription Billing.

News headlines about MTBC stock have been trending negative this week, according to InfoTrie Sentiment. The research group identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Medical Transcription Billing earned a daily sentiment score of -2.1 on InfoTrie's scale. They also gave press coverage about the technology company a news buzz of 2.0 out of 10, meaning that recent news coverage is very unlikely to have an effect on the company's share price in the near term. View News Stories for Medical Transcription Billing.

Medical Transcription Billing saw a increase in short interest in the month of January. As of January 15th, there was short interest totalling 65,200 shares, an increase of 35.0% from the December 31st total of 48,300 shares. Based on an average daily volume of 49,400 shares, the days-to-cover ratio is currently 1.3 days. Currently, 1.0% of the shares of the stock are sold short. View Medical Transcription Billing's Current Options Chain.

Some companies that are related to Medical Transcription Billing include eGain (EGAN), MiX Telematics (MIXT), Xunlei (XNET), Red Violet (RDVT), ChannelAdvisor (ECOM), DIRTT Environmental (DRTT), Iclick Interactive Asia Group (ICLK), Smith Micro Software (SMSI), SharpSpring (SHSP), MAM Software Group (MAMS), Inspired Entertainment (INSE), Great Elm Capital Group (GEC), Aware (AWRE), Cyren (CYRN) and Where Food Comes From (WFCF).

Based on aggregate information from My MarketBeat watchlists, some companies that other Medical Transcription Billing investors own include BlackBerry (BB), Verastem (VSTM), NVIDIA (NVDA), Micron Technology (MU), Sophiris Bio (SPHS), AbbVie (ABBV), Alibaba Group (BABA), Advanced Micro Devices (AMD), Microbot Medical (MBOT) and Etsy (ETSY).

Shares of MTBC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MTBC stock can currently be purchased for approximately $6.61.

Medical Transcription Billing has a market capitalization of $80.75 million and generates $50.55 million in revenue each year. The technology company earns $-2,140,000.00 in net income (profit) each year or ($0.59) on an earnings per share basis. Medical Transcription Billing employs 2,400 workers across the globe.View Additional Information About Medical Transcription Billing.

The official website for Medical Transcription Billing is http://www.mtbc.com/.

Medical Transcription Billing's mailing address is 7 CLYDE ROAD, SOMERSET NJ, 08873. The technology company can be reached via phone at 732-873-5133.